Removing Fusion Tags After Purification: TEV vs Thrombin Cleavage
9 May 2025
When it comes to protein purification, fusion tags are invaluable tools. They enhance protein solubility, improve expression levels, and simplify the purification process. However, once the target protein is purified, the fusion tag often needs to be removed to ensure the protein's native function and structure. Two widely used proteases for this purpose are TEV protease and thrombin. Each has its own set of advantages and disadvantages, depending on the specific requirements of the purification process.
TEV protease, derived from the Tobacco Etch Virus, is favored for its high specificity. It recognizes a seven-amino-acid sequence, making it unlikely to cleave at unintended sites within the target protein. This specificity is particularly advantageous when working with complex proteins where unintended cleavage could compromise functionality. Additionally, TEV protease functions effectively across a wide range of conditions, maintaining activity in various buffers and temperatures, which adds a layer of flexibility to experimental design. Furthermore, TEV protease can be easily removed from the reaction mix, as it is often tagged itself for purification purposes.
On the other hand, thrombin, a mammalian serine protease, recognizes a simpler cleavage site, typically Leu-Val-Pro-Arg-Gly-Ser. Its simplicity can be advantageous when designing constructs, as it requires less complex engineering of the fusion protein. However, this simplicity can also lead to less specificity, with a higher potential for unintended cleavage events. Thrombin is also a well-established tool in the laboratory, with well-characterized activity and availability of commercial preparations, making it a convenient choice for many researchers.
The choice between TEV protease and thrombin often boils down to the specific needs of the experiment. If high specificity is paramount, TEV protease may be the better option. This is especially true for proteins that have sequences similar to the thrombin cleavage site or for cases where precise control over cleavage is essential. Conversely, if the experimental setup favors simplicity and cost-effectiveness, and if the protein construct allows for it, thrombin might be the more practical choice.
In practice, the decision is often informed by a combination of factors, including the nature of the target protein, the conditions of the purification process, and the availability of resources. It's also not uncommon for researchers to initially test both methods on small scales to determine which provides the best results for their specific system.
Ultimately, the goal is to achieve efficient tag removal while preserving the integrity and functionality of the target protein. Both TEV protease and thrombin offer viable pathways to this end, with their distinct characteristics catering to different experimental needs. By carefully considering the attributes of each protease, researchers can make informed decisions that enhance the success of their protein purification endeavors.
Curious to see how Eureka LS fits into your workflow? From reducing screening time to simplifying Markush drafting, our AI Agents are ready to deliver immediate value. Explore Eureka LS today and unlock powerful capabilities that help you innovate with confidence.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.